×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Catalent Inc.. (CTLT) NEW YORK STOCK EXCHANGE INC.

$55.48 (0.49) (-0.88%)

Market Cap: $10.04B

As of 06/14/24 04:00 PM EDT. Market closed.

Catalent Inc.. (CTLT)
NEW YORK STOCK EXCHANGE INC.

$55.48
(0.49) (-0.88%)

Market Cap: $10.04B

As of 06/14/24 04:00 PM EDT. Market closed.

Add to Portfolio

Catalent is a leading provider of advanced development and manufacturing solutions for a wide array of health products, including drugs, biologics, cell and gene therapies, and consumer health products. Operating over fifty facilities across four continents, Catalent offers innovative technologies such as oral, injectable, and respiratory delivery systems, along with robust capabilities in ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Alessandro Maselli
Full Time Employees
11,908
CEO Compensation (Base)
$1.03M
CEO Compensation (Total)
$8.51M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Alessandro Maselli
Full Time Employees
11,908
CEO Compensation (Base)
$1.03M
CEO Compensation (Total)
$8.51M
Address
.
PRICE CHART FOR CATALENT INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$55.95
Previous Close
$55.97
Days Range
$55.19 - $56.10
52 week range
$31.80 - $60.20
Volume
1,522,347
Avg. Volume (30 days)
1,589,741
Market Cap
$10.04B
Dividend Yield
-
P/E
(8.54)
Shares Outstanding
180,979,849
Open
$55.95
Previous Close
$55.97
Days Range
$55.19 - $56.10
52 week range
$31.80 - $60.20
Volume
1,522,347
Avg. Volume (30 days)
1,589,741
Market Cap
$10.04B
Dividend Yield
-
P/E
(8.54)
Shares Outstanding
180,979,849
FINANCIAL STATEMENTS FOR CATALENT INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CATALENT INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hopson RickyPres. BioProduct Delivery, CoSJun 04, 2024 Sale$54.261,40176,02320,617Jun 05, 2024, 09:35 PM
Gunther ScottSVP, Quality & Reg. AffairsMar 15, 2024 Sale$56.2038721,74929,506Mar 19, 2024, 01:38 PM
Kreuzburg ChristaDirectorJan 25, 2024 Option Exercise$50.4152326,36418,283Jan 29, 2024, 04:09 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerDec 08, 2023 Option Exercise$37.1836713,64596,496Dec 12, 2023, 07:28 PM
Maselli AlessandroPresident & CEODec 08, 2023 Option Exercise$37.181,92471,53487,938Dec 12, 2023, 07:27 PM
Gunther ScottSVP, Quality & Reg. AffairsDec 08, 2023 Option Exercise$37.182509,29529,893Dec 12, 2023, 07:26 PM
Hopson RickyPres. Clinical Dev Supply DivDec 08, 2023 Option Exercise$37.182569,51822,018Dec 12, 2023, 07:24 PM
Kreuzburg ChristaDirectorOct 27, 2023 Option Exercise$39.321,24548,95318,806Oct 31, 2023, 04:32 PM
Hunt PatriciaPres. Consumer Health DivOct 16, 2023 Option Exercise$46.52221,02311,267Oct 18, 2023, 02:38 PM
Ryan Michelle RDirectorAug 31, 2023 Buy$49.981,00049,9801,979Sep 05, 2023, 06:00 PM
GREISCH JOHN JExecutive ChairAug 30, 2023 Buy$50.2421,0001,055,04034,000Sep 01, 2023, 01:52 PM
Maselli AlessandroPresident & CEOAug 24, 2023 Sale$44.542,07192,24588,105Aug 25, 2023, 07:16 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 24, 2023 Sale$44.5726911,98929,932Aug 25, 2023, 07:12 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Aug 24, 2023 Sale$44.5039017,35524,449Aug 25, 2023, 07:08 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerAug 24, 2023 Sale$44.4939617,61896,552Aug 25, 2023, 07:05 PM
Fasman Steven LEVP & Chief Admin OfficerAug 24, 2023 Sale$44.6581736,47973,789Aug 25, 2023, 07:02 PM
Carletti LorenzoSVP Global Ops Ph & Cons HlthAug 24, 2023 Sale$44.712169,6578,746Aug 25, 2023, 06:58 PM
Arnold JonathanSVP, CCO & Div. Head BioP Del.Aug 24, 2023 Sale$44.87873,90457,399Aug 25, 2023, 06:56 PM
Hopson RickyPres. Clinical Dev Supply DivAug 24, 2023 Sale$44.5627612,29922,040Aug 25, 2023, 06:52 PM
Hawkeswood Thomas WPres. Pharma Prod Delivery DivAug 24, 2023 Sale$44.721476,5747,533Aug 25, 2023, 06:48 PM
Lickfold CharlesSVP, CIOAug 24, 2023 Sale$44.721908,49711,339Aug 25, 2023, 06:45 PM
Hunt PatriciaPres. Consumer Health DivAug 24, 2023 Sale$44.771064,74611,289Aug 25, 2023, 06:39 PM
Pravda RicardoChief Transformation OfficerAug 24, 2023 Sale$44.4737916,85430,224Aug 25, 2023, 06:37 PM
Pravda RicardoChief Transformation OfficerAug 01, 2023 Sale$47.5626912,79319,961Aug 03, 2023, 05:13 PM
Maselli AlessandroPresident & CEOAug 01, 2023 Sale$47.131,48569,99586,707Aug 03, 2023, 05:05 PM
Lickfold CharlesSVP, CIOAug 01, 2023 Sale$47.901356,4675,570Aug 03, 2023, 05:00 PM
Hunt PatriciaPres. Consumer Health DivAug 01, 2023 Sale$47.951617,7209,154Aug 03, 2023, 04:51 PM
Hopson RickyPres. Clinical Dev Supply DivAug 01, 2023 Sale$47.861959,33316,257Aug 03, 2023, 04:47 PM
Hawkeswood Thomas WPres. Pharma Prod Delivery DivAug 01, 2023 Sale$47.9725812,3765,106Aug 03, 2023, 04:41 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 01, 2023 Sale$47.901909,10123,798Aug 03, 2023, 04:37 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Aug 01, 2023 Sale$47.7227613,17117,757Aug 03, 2023, 04:30 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerAug 01, 2023 Sale$47.5928113,37386,708Aug 03, 2023, 04:21 PM
Carletti LorenzoSVP Global Ops Ph & Cons HlthAug 01, 2023 Sale$47.7738318,2964,602Aug 03, 2023, 04:16 PM
Arnold JonathanSVP, CCO & Div. Head BioP Del.Aug 01, 2023 Sale$47.80622,96455,896Aug 03, 2023, 04:09 PM
Fasman Steven LEVP & Chief Admin OfficerAug 01, 2023 Sale$47.051,63777,02660,740Aug 03, 2023, 04:02 PM
Boerman ManjaPres. BioModalities DivisionMay 01, 2023 Sale$49.861,44672,09814,414May 03, 2023, 07:00 PM
Gargiulo MarioSVP, Ops, Biologics EuropeMay 01, 2023 Sale$49.8667833,8055,676May 03, 2023, 06:58 PM
Hopson RickyPres. Clinical Dev Supply DivJan 23, 2023 Sale$49.3664331,73816,452Jan 25, 2023, 05:06 PM
Boerman ManjaPres. BioModalities DivisionDec 05, 2022 Sale$51.7078040,32615,860Dec 07, 2022, 04:51 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Oct 31, 2022 Sale$65.832,451161,34917,792Nov 02, 2022, 07:58 PM
Kreuzburg ChristaDirectorOct 27, 2022 Option Exercise$66.2742127,90013,058Oct 31, 2022, 05:01 PM
Hawkeswood Thomas WPres. Pharma Prod Delivery DivOct 10, 2022 Sale$77.4693072,0385,364Oct 12, 2022, 06:13 PM
Hopson RickyPres. Clinical Dev Supply DivAug 31, 2022 Sale$89.592,216198,53117,095Sep 02, 2022, 02:43 PM
Riley Michael A.Pres. Bio Product Delivery DivAug 26, 2022 Sale$104.072,491259,2386,592Aug 30, 2022, 02:38 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 26, 2022 Sale$104.071,639170,57123,988Aug 30, 2022, 02:37 PM
Schmidt Kay ASVP, Enterprise FunctionsAug 25, 2022 Sale$103.041,321136,11617,388Aug 26, 2022, 08:23 PM
Riley Michael A.Pres. Bio Product Delivery DivAug 25, 2022 Sale$103.041,482152,7059,083Aug 26, 2022, 08:23 PM
Pravda RicardoSVP & Chief HR OfficerAug 25, 2022 Sale$103.041,747180,01120,008Aug 26, 2022, 08:21 PM
Maselli AlessandroPresident & CEOAug 25, 2022 Sale$103.044,646478,72441,190Aug 26, 2022, 08:20 PM
Hunt PatriciaPres. Consumer Health DivAug 25, 2022 Sale$103.0433934,9319,315Aug 26, 2022, 08:20 PM
Hopson RickyPres. Clinical Dev Supply DivAug 25, 2022 Sale$103.041,517156,31219,311Aug 26, 2022, 08:19 PM
Hawkeswood Thomas WPres. Pharma Prod Delivery DivAug 25, 2022 Sale$103.0467169,1406,294Aug 26, 2022, 08:19 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 25, 2022 Sale$103.041,840189,59425,627Aug 26, 2022, 08:18 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Aug 25, 2022 Sale$103.041,670172,07720,243Aug 26, 2022, 08:18 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerAug 25, 2022 Sale$103.041,645169,50186,769Aug 26, 2022, 08:17 PM
Gargiulo MarioSVP Global Ops BiologicsAug 25, 2022 Sale$103.041,586163,4216,354Aug 26, 2022, 08:17 PM
Fasman Steven LEVP & Chief Admin OfficerAug 25, 2022 Sale$103.044,811495,72561,853Aug 26, 2022, 08:16 PM
Chiminski John RExecutive ChairAug 25, 2022 Sale$103.0438,9344,011,759229,888Aug 26, 2022, 08:16 PM
Castellano Thomas PSVP, Chief Financial OfficerAug 25, 2022 Sale$103.041,414145,69920,099Aug 26, 2022, 08:16 PM
Carletti LorenzoSVP Global Ops Ph & Cons HlthAug 25, 2022 Sale$103.041,033106,4404,985Aug 26, 2022, 08:15 PM
Boerman ManjaPres. BioModalities DivisionAug 25, 2022 Sale$103.043,296339,62016,640Aug 26, 2022, 08:15 PM
Arnold JonathanSVP & Chief Commercial OfcrAug 25, 2022 Sale$103.0438439,56755,958Aug 26, 2022, 08:14 PM
Schmidt Kay ASVP, Enterprise FunctionsJul 26, 2022 Sale$106.9032334,52913,455Jul 28, 2022, 08:03 PM
Pravda RicardoSVP & Chief HR OfficerJul 26, 2022 Sale$106.9042745,64615,337Jul 28, 2022, 08:01 PM
Maselli AlessandroPresident & CEOJul 26, 2022 Sale$106.9081687,23025,083Jul 28, 2022, 08:00 PM
Hopson RickyPres, Clinical Dev & SupplyJul 27, 2022 Sale$107.6759163,63317,095Jul 28, 2022, 07:59 PM
Hopson RickyPres, Clinical Dev & SupplyJul 26, 2022 Sale$106.9031233,35317,035Jul 28, 2022, 07:59 PM
Gunther ScottSVP, Quality & Reg. AffairsJul 27, 2022 Sale$107.6739442,42222,350Jul 28, 2022, 07:58 PM
Gunther ScottSVP, Quality & Reg. AffairsJul 26, 2022 Sale$106.9045048,10521,629Jul 28, 2022, 07:58 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Jul 27, 2022 Sale$107.6738841,77617,023Jul 28, 2022, 07:46 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Jul 26, 2022 Sale$106.9040943,72216,110Jul 28, 2022, 07:46 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerJul 26, 2022 Sale$106.9040343,08179,784Jul 28, 2022, 07:45 PM
Gargiulo MarioSVP Global Ops BiologicsJul 26, 2022 Sale$106.90969103,5863,671Jul 28, 2022, 07:43 PM
Fasman Steven LEVP & Chief Admin OfficerJul 26, 2022 Sale$106.902,546272,16753,721Jul 28, 2022, 07:42 PM
Chiminski John RExecutive ChairJul 26, 2022 Sale$106.909,6911,035,968132,382Jul 28, 2022, 07:41 PM
Castellano Thomas PSVP, Chief Financial OfficerJul 26, 2022 Sale$106.9034737,09415,051Jul 28, 2022, 07:39 PM
Carletti LorenzoSVP Global Ops Ph & Cons HlthJul 26, 2022 Sale$106.9063167,4542,949Jul 28, 2022, 07:39 PM
Arnold JonathanSVP & Chief Commercial OfcrJul 26, 2022 Sale$106.909410,04948,698Jul 28, 2022, 07:35 PM
Gennadios AristipposGroup Pres. Pharma & ConsumerJul 01, 2022 Option Exercise$107.0218,6892,000,09780,187Jul 05, 2022, 09:46 PM
Arnold JonathanSVP & Chief Commercial OfcrJul 01, 2022 Option Exercise$107.022,804300,08448,792Jul 05, 2022, 09:46 PM
Gargiulo MarioSVP Global Ops Large MoleculeJun 10, 2022 Sale$106.5911812,5784,640Jun 13, 2022, 04:58 PM
Fasman Steven LSVP & General CounselJun 10, 2022 Sale$107.075,000535,35258,129Jun 13, 2022, 04:57 PM
Zippelius PeterDirectorFeb 06, 2022 Sale$102.65487,09249,999,9954,330,462Feb 08, 2022, 09:31 PM
Hopson RickyVP, Chief Accounting OfficerJan 31, 2022 Sale$103.392,325240,38217,073Feb 01, 2022, 03:38 PM
Whitlow Ricci SPresident, CSSJan 21, 2022 Sale$102.3718418,8362,923Jan 24, 2022, 04:42 PM
Flynn KarenChief Commercial OfficerJan 10, 2022 Sale$116.642,472288,33433,223Jan 11, 2022, 06:54 PM
Zippelius PeterDirectorNov 18, 2021 Option Exercise$49.547,822,946387,555,7957,822,946Dec 01, 2021, 08:35 PM
Zippelius PeterDirectorNov 30, 2021 Sale$129.303,000,000387,900,0094,822,946Dec 01, 2021, 08:35 PM
CARROLL J MARTINDirectorNov 29, 2021 Option Exercise$134.123,136420,60011,663Dec 01, 2021, 01:41 PM
CARROLL J MARTINDirectorNov 29, 2021 Option Exercise$134.123,136420,6000Dec 01, 2021, 01:41 PM
LUCIER GREGORY TDirectorNov 23, 2021 Sale$127.355,068645,4072,400Nov 24, 2021, 12:40 PM
Arnold JonathanPres. Oral & Specialty Deliv.Nov 01, 2021 Option Exercise$44.777,559338,42152,643Nov 03, 2021, 03:35 PM
Arnold JonathanPres. Oral & Specialty Deliv.Nov 01, 2021 Sale$140.0210,6721,494,29341,971Nov 03, 2021, 03:35 PM
Kreuzburg ChristaDirectorOct 28, 2021 Option Exercise$135.5063886,4499,330Nov 01, 2021, 08:00 AM
Castellano Thomas PSVP, Chief Financial OfficerOct 20, 2021 Sale$134.002,307309,13815,398Oct 21, 2021, 07:16 PM
Arnold JonathanPres. Oral & Specialty Deliv.Oct 14, 2021 Sale$129.411,661214,95045,084Oct 18, 2021, 02:33 PM
Schmidt Kay ASVP, Technical OperationsOct 04, 2021 Sale$131.252,191287,56913,778Oct 06, 2021, 05:37 PM
Fasman Steven LSVP & General CounselOct 04, 2021 Option Exercise$51.5117,259889,05091,847Oct 06, 2021, 05:37 PM
Fasman Steven LSVP & General CounselOct 04, 2021 Sale$129.0534,7144,479,97571,334Oct 06, 2021, 05:37 PM
Pravda RicardoSVP & Chief HR OfficerOct 01, 2021 Option Exercise$63.303,818241,69416,653Oct 05, 2021, 06:51 PM
Pravda RicardoSVP & Chief HR OfficerOct 01, 2021 Sale$132.684,906650,92811,747Oct 05, 2021, 06:51 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Oct 01, 2021 Sale$131.662,055270,55714,357Oct 05, 2021, 06:51 PM
Chiminski John RChair & CEOOct 01, 2021 Option Exercise$39.3975,8382,986,973294,710Oct 05, 2021, 06:51 PM
Chiminski John RChair & CEOOct 01, 2021 Sale$130.90152,63719,979,610290,109Oct 05, 2021, 06:51 PM
Kreuzburg ChristaDirectorAug 27, 2021 Option Exercise$129.8519925,8408,566Aug 31, 2021, 05:28 PM
Castellano Thomas PSVP, Chief Financial OfficerAug 27, 2021 Sale$131.132,093274,45819,640Aug 30, 2021, 09:43 PM
Schmidt Kay ASVP, Technical OperationsAug 27, 2021 Sale$131.13825108,18316,731Aug 30, 2021, 09:43 PM
Hopson RickyVP, Chief Accounting OfficerAug 27, 2021 Sale$131.131,471192,89420,758Aug 30, 2021, 09:42 PM
Pravda RicardoSVP & Chief HR OfficerAug 27, 2021 Sale$131.1369290,74213,474Aug 30, 2021, 09:42 PM
Maselli AlessandroPresident & COOAug 27, 2021 Sale$131.133,743490,82429,359Aug 30, 2021, 09:41 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 27, 2021 Sale$130.784,173545,72522,062Aug 30, 2021, 09:41 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Aug 27, 2021 Sale$131.131,698222,66116,127Aug 30, 2021, 09:40 PM
Gennadios AristipposPresident Softgel & Oral TechAug 27, 2021 Sale$131.132,262296,61959,572Aug 30, 2021, 09:40 PM
Fasman Steven LSVP & General CounselAug 27, 2021 Sale$131.136,111801,34480,238Aug 30, 2021, 09:39 PM
Chiminski John RChair & CEOAug 27, 2021 Sale$131.0644,4885,830,710270,760Aug 30, 2021, 09:39 PM
Arnold JonathanPres. Oral & Specialty Deliv.Aug 27, 2021 Sale$131.1345259,27147,162Aug 30, 2021, 09:38 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Dec 19, 2019 Sale$54.001,84699,68415,733Aug 23, 2021, 06:35 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Jan 13, 2020 Sale$58.001,68097,44011,647Aug 23, 2021, 06:35 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Dec 20, 2019 Sale$56.002,406134,73613,327Aug 23, 2021, 06:35 PM
Castellano Thomas PSVP, Chief Financial OfficerJul 26, 2021 Sale$113.0555562,74314,463Jul 28, 2021, 04:29 PM
Schmidt Kay ASVP, Technical OperationsJul 26, 2021 Sale$113.0554761,83813,319Jul 28, 2021, 04:29 PM
Hopson RickyVP, Chief Accounting OfficerJul 26, 2021 Sale$113.0536040,69816,056Jul 28, 2021, 04:28 PM
Pravda RicardoSVP & Chief HR OfficerJul 26, 2021 Sale$113.0545851,77710,612Jul 28, 2021, 04:28 PM
Maselli AlessandroPresident & COOJul 26, 2021 Sale$113.05993112,25918,625Jul 28, 2021, 04:28 PM
Gunther ScottSVP, Quality & Reg. AffairsJul 26, 2021 Sale$113.041,079121,96715,900Jul 28, 2021, 04:27 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Jul 26, 2021 Sale$113.0545150,98616,605Jul 28, 2021, 04:27 PM
Gennadios AristipposPresident Softgel & Oral TechJul 26, 2021 Sale$113.0546552,56850,850Jul 28, 2021, 04:27 PM
Fasman Steven LSVP & General CounselJul 26, 2021 Sale$113.051,549175,11467,363Jul 28, 2021, 04:26 PM
Chiminski John RChair & CEOJul 26, 2021 Sale$113.0511,1371,259,038152,481Jul 28, 2021, 04:25 PM
Arnold JonathanPres. Oral & Specialty Deliv.Jul 26, 2021 Sale$113.0512013,56638,482Jul 28, 2021, 04:25 PM
Fasman Steven LSVP & General CounselJul 15, 2021 Sale$109.864,500494,35370,099Jul 16, 2021, 01:06 PM
Pravda RicardoSVP & Chief HR OfficerJun 23, 2021 Sale$110.582,800309,62411,070Jun 24, 2021, 06:10 PM
Schmidt Kay ASVP, Technical OperationsMar 22, 2021 Sale$105.771,400148,07813,866Mar 23, 2021, 07:27 PM
Fasman Steven LSVP & General CounselMar 18, 2021 Option Exercise$38.7821,647839,44594,954Mar 22, 2021, 02:20 PM
Fasman Steven LSVP & General CounselMar 18, 2021 Sale$104.5321,6472,262,77082,039Mar 22, 2021, 02:20 PM
Chiminski John RChair & CEOMar 19, 2021 Option Exercise$42.06183,0247,698,674346,642Mar 22, 2021, 02:19 PM
Chiminski John RChair & CEOMar 18, 2021 Option Exercise$36.0242,2201,520,764205,838Mar 22, 2021, 02:19 PM
Chiminski John RChair & CEOMar 19, 2021 Sale$106.01183,02419,402,784276,059Mar 22, 2021, 02:19 PM
Chiminski John RChair & CEOMar 18, 2021 Sale$105.1642,2204,439,855163,618Mar 22, 2021, 02:19 PM
Joseph WettenySVP & Chief Financial OfficerFeb 16, 2021 Option Exercise$52.565,000262,79954,823Feb 18, 2021, 09:56 AM
Joseph WettenySVP & Chief Financial OfficerFeb 16, 2021 Sale$124.545,000622,68553,024Feb 18, 2021, 09:56 AM
Joseph WettenySVP & Chief Financial OfficerFeb 08, 2021 Sale$113.734,604523,61349,823Feb 10, 2021, 09:05 AM
Whitlow Ricci SPresident, CSSJan 21, 2021 Sale$118.8569282,2442,576Jan 25, 2021, 07:17 AM
Flynn KarenPres. Biologics & CCOJan 11, 2021 Sale$112.302,478278,27935,644Jan 11, 2021, 07:12 PM
Gunther ScottSVP, Quality & Reg. AffairsJan 06, 2021 Sale$104.78616,39216,509Jan 07, 2021, 07:04 AM
Whitlow Ricci SPresident, CSSJan 04, 2021 Sale$104.42838,6673,268Jan 05, 2021, 09:47 PM
Schmidt Kay ASVP, Technical OperationsJan 04, 2021 Sale$104.42737,62315,266Jan 05, 2021, 09:47 PM
Pravda RicardoSVP & Chief HR OfficerJan 04, 2021 Sale$104.42788,14513,870Jan 05, 2021, 09:46 PM
Maselli AlessandroPresident & COOJan 04, 2021 Sale$104.4214815,45419,618Jan 05, 2021, 09:46 PM
Joseph WettenySVP & Chief Financial OfficerJan 04, 2021 Sale$104.4217217,96054,427Jan 05, 2021, 09:46 PM
Gunther ScottSVP, Quality & Reg. AffairsJan 04, 2021 Sale$104.4212012,53016,570Jan 05, 2021, 09:45 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Jan 04, 2021 Sale$104.4212613,15717,076Jan 05, 2021, 09:45 PM
Gennadios AristipposPresident Softgel & Oral TechJan 04, 2021 Sale$104.4211011,48651,315Jan 05, 2021, 09:45 PM
Flynn KarenPres. Biologics & CCOJan 04, 2021 Sale$104.429910,33837,022Jan 05, 2021, 09:44 PM
Fasman Steven LSVP & General CounselJan 04, 2021 Sale$104.4218919,73573,307Jan 05, 2021, 09:44 PM
Arnold JonathanPres. Oral & Specialty Deliv.Jan 04, 2021 Sale$104.42161,67138,602Jan 05, 2021, 09:44 PM
Gennadios AristipposPresident Softgel & Oral TechDec 21, 2020 Option Exercise$32.6813,662446,52661,151Dec 23, 2020, 07:19 AM
Gennadios AristipposPresident Softgel & Oral TechDec 21, 2020 Sale$102.8413,6621,405,04451,425Dec 23, 2020, 07:19 AM
Zippelius PeterDirectorNov 23, 2020 Option Exercise$49.545,392,280267,138,4115,392,280Nov 25, 2020, 05:53 PM
Zippelius PeterDirectorNov 23, 2020 Sale$99.265,392,280535,237,7240Nov 25, 2020, 05:53 PM
Fasman Steven LSVP & General CounselNov 11, 2020 Sale$100.992,425244,90173,496Nov 12, 2020, 12:21 PM
Schmidt Kay ASVP, Technical OperationsOct 23, 2020 Option Exercise$94.0242539,95815,339Oct 26, 2020, 06:51 PM
Schmidt Kay ASVP, Technical OperationsOct 14, 2020 Sale$93.152,985278,04517,564Oct 16, 2020, 06:13 PM
Fasman Steven LSVP & General CounselOct 14, 2020 Option Exercise$93.109,515885,88381,431Oct 16, 2020, 06:13 PM
Fasman Steven LSVP & General CounselOct 14, 2020 Option Exercise$26.1815,025393,42687,460Oct 16, 2020, 06:13 PM
Fasman Steven LSVP & General CounselOct 14, 2020 Sale$93.095,510512,93478,942Oct 16, 2020, 06:13 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Oct 12, 2020 Sale$94.991,680159,58317,202Oct 13, 2020, 08:24 AM
Arnold JonathanPres. Oral & Specialty Deliv.Oct 07, 2020 Option Exercise$91.5023,4142,142,38154,546Oct 09, 2020, 03:24 PM
Arnold JonathanPres. Oral & Specialty Deliv.Oct 07, 2020 Option Exercise$30.8439,3421,213,36477,960Oct 09, 2020, 03:24 PM
Arnold JonathanPres. Oral & Specialty Deliv.Oct 07, 2020 Sale$91.5015,9281,457,41238,618Oct 09, 2020, 03:24 PM
Arnold JonathanPres. Oral & Specialty Deliv.Oct 04, 2020 Option Exercise$85.8824020,61138,618Oct 06, 2020, 09:25 PM
Gunther ScottSVP, Quality & Reg. AffairsOct 02, 2020 Option Exercise$84.945,200441,68821,049Oct 05, 2020, 07:55 PM
Gunther ScottSVP, Quality & Reg. AffairsOct 02, 2020 Option Exercise$36.027,347264,63926,249Oct 05, 2020, 07:55 PM
Gunther ScottSVP, Quality & Reg. AffairsOct 02, 2020 Sale$85.484,359372,60818,384Oct 05, 2020, 07:55 PM
Chiminski John RChair & CEOOct 02, 2020 Option Exercise$86.0186,2517,418,449355,849Oct 05, 2020, 07:55 PM
Chiminski John RChair & CEOOct 02, 2020 Option Exercise$29.90138,1354,130,817404,337Oct 05, 2020, 07:55 PM
Chiminski John RChair & CEOOct 02, 2020 Sale$86.01182,23115,673,809346,658Oct 05, 2020, 07:55 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Sep 02, 2020 Sale$89.502,250201,37818,888Sep 08, 2020, 01:21 PM
Schmidt Kay ASVP, Technical OperationsAug 27, 2020 Option Exercise$87.7190479,29018,749Aug 31, 2020, 05:25 PM
Pravda RicardoSVP & Chief HR OfficerAug 27, 2020 Option Exercise$87.7194382,71111,699Aug 31, 2020, 05:24 PM
Maselli AlessandroPresident & COOAug 27, 2020 Option Exercise$87.714,217369,87319,766Aug 31, 2020, 05:24 PM
Joseph WettenySVP & Chief Financial OfficerAug 27, 2020 Option Exercise$87.713,480305,23154,599Aug 31, 2020, 05:24 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 27, 2020 Option Exercise$87.712,823247,60518,902Aug 31, 2020, 05:23 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Aug 27, 2020 Option Exercise$87.712,392209,80221,132Aug 31, 2020, 05:23 PM
Gennadios AristipposPresident Softgel & Oral TechAug 27, 2020 Option Exercise$87.714,384384,52151,425Aug 31, 2020, 05:23 PM
Fasman Steven LSVP & General CounselAug 27, 2020 Option Exercise$87.716,676585,55275,883Aug 31, 2020, 05:22 PM
Chiminski John RChair & CEOAug 27, 2020 Option Exercise$87.7158,9785,172,960303,965Aug 31, 2020, 05:22 PM
Arnold JonathanPres. Oral & Specialty Deliv.Aug 27, 2020 Option Exercise$87.713,023265,14738,858Aug 31, 2020, 05:21 PM
Kreuzburg ChristaDirectorAug 22, 2020 Option Exercise$86.4995182,2525,979Aug 24, 2020, 06:16 PM
Chiminski John RChair & CEOAug 23, 2020 Option Exercise$86.494,649402,092223,918Aug 24, 2020, 06:15 PM
LUCIER GREGORY TDirectorJul 30, 2020 Sale$90.0924,0002,162,16016,921Aug 03, 2020, 12:02 PM
Schmidt Kay ASVP, Technical OperationsJul 24, 2020 Option Exercise$81.6450441,14711,517Jul 28, 2020, 08:12 AM
Pravda RicardoSVP & Chief HR OfficerJul 24, 2020 Option Exercise$81.641,949159,1169,123Jul 28, 2020, 08:12 AM
Maselli AlessandroPresident & COOJul 24, 2020 Option Exercise$81.6494076,74212,177Jul 28, 2020, 08:11 AM
Joseph WettenySVP & Chief Financial OfficerJul 24, 2020 Option Exercise$81.6476162,12846,015Jul 28, 2020, 08:11 AM
Gunther ScottSVP, Quality & Reg. AffairsJul 24, 2020 Option Exercise$81.6464652,73912,719Jul 28, 2020, 08:11 AM
Grippo Michael JSVP, Strategy & Corp. Dev.Jul 24, 2020 Option Exercise$81.6453243,43215,750Jul 28, 2020, 08:11 AM
Gennadios AristipposPresident Softgel & Oral TechJul 24, 2020 Option Exercise$81.6498480,33443,536Jul 28, 2020, 08:10 AM
Fasman Steven LSVP & General CounselJul 24, 2020 Option Exercise$81.641,227100,17262,039Jul 28, 2020, 08:10 AM
Chiminski John RChair & CEOJul 24, 2020 Option Exercise$81.646,642542,253207,965Jul 28, 2020, 08:10 AM
Arnold JonathanPres. Oral & Specialty Deliv.Jul 24, 2020 Option Exercise$81.643,796309,90530,713Jul 28, 2020, 08:09 AM
Gunther ScottSVP, Quality & Reg. AffairsJun 29, 2020 Sale$72.002,824203,31813,765Jul 01, 2020, 06:15 PM
Gennadios AristipposPresident Softgel & Oral TechJun 25, 2020 Option Exercise$73.0013,9301,016,89052,845Jun 29, 2020, 06:54 PM
Gennadios AristipposPresident Softgel & Oral TechJun 25, 2020 Option Exercise$27.9722,255622,54159,736Jun 29, 2020, 06:54 PM
Gennadios AristipposPresident Softgel & Oral TechJun 25, 2020 Sale$73.008,325607,72544,520Jun 29, 2020, 06:54 PM
CARROLL J MARTINDirectorMay 12, 2020 Option Exercise$72.293,600260,2448,527May 13, 2020, 05:08 PM
CARROLL J MARTINDirectorMay 12, 2020 Option Exercise$72.293,600260,2440May 13, 2020, 05:08 PM
Whitlow Ricci SPresident, CSSApr 09, 2020 Option Exercise$56.4624013,5502,704Apr 13, 2020, 12:22 PM
Schmidt Kay ASVP, Technical OperationsApr 09, 2020 Option Exercise$56.4622612,76012,021Apr 13, 2020, 12:22 PM
Pravda RicardoSVP & Chief HR OfficerApr 09, 2020 Option Exercise$56.4622612,76011,072Apr 13, 2020, 12:21 PM
Maselli AlessandroPresident & COOApr 09, 2020 Option Exercise$56.4631517,78513,117Apr 13, 2020, 12:21 PM
Joseph WettenySVP & Chief Financial OfficerApr 09, 2020 Option Exercise$56.4634919,70546,776Apr 13, 2020, 12:20 PM
Gunther ScottSVP, Quality & Reg. AffairsApr 09, 2020 Option Exercise$56.4624313,72016,189Apr 13, 2020, 12:20 PM
Grippo Michael JSVP, Strategy & Corp. Dev.Apr 09, 2020 Option Exercise$56.4625614,45416,282Apr 13, 2020, 12:20 PM
Gennadios AristipposPresident Softgel & Oral TechApr 09, 2020 Option Exercise$56.4627915,75244,520Apr 13, 2020, 12:19 PM
Flynn KarenPres. Biologics & CCOApr 09, 2020 Option Exercise$56.4635920,26935,645Apr 13, 2020, 12:19 PM
Fasman Steven LSVP & General CounselApr 09, 2020 Option Exercise$56.4638621,79463,206Apr 13, 2020, 12:19 PM
BUZY PETER LPresident, Gene TherapyApr 09, 2020 Option Exercise$56.4626615,01845,950Apr 13, 2020, 12:12 PM
Arnold JonathanPres. Oral & Specialty Deliv.Apr 09, 2020 Option Exercise$56.4626414,90534,509Apr 13, 2020, 12:12 PM
LUCIER GREGORY TDirectorFeb 13, 2020 Buy$59.712,000119,42040,921Feb 14, 2020, 02:43 PM
Schmidt Kay ASVP, Technical OperationsFeb 02, 2020 Option Exercise$61.1020712,64811,795Feb 04, 2020, 06:22 PM
Maselli AlessandroPresident & COODec 16, 2019 Sale$53.187,268386,51212,802Dec 18, 2019, 08:51 AM
Pravda RicardoSVP & Chief HR OfficerNov 26, 2019 Sale$52.732,612137,71812,161Nov 27, 2019, 11:36 AM
Gennadios AristipposPresident Softgel & Oral TechNov 25, 2019 Option Exercise$52.5578,6154,131,21889,497Nov 27, 2019, 11:36 AM
Gennadios AristipposPresident Softgel & Oral TechNov 25, 2019 Option Exercise$18.35123,8802,272,760141,122Nov 27, 2019, 11:36 AM
Gennadios AristipposPresident Softgel & Oral TechNov 25, 2019 Sale$52.5545,2562,378,20344,241Nov 27, 2019, 11:36 AM
Grippo Michael JSVP, Strategy & Corp. Dev.Nov 22, 2019 Sale$52.0037619,55210,702Nov 26, 2019, 05:07 PM
Chiminski John RChair & CEOOct 07, 2019 Option Exercise$48.8434,0891,664,907321,300Oct 09, 2019, 01:13 PM
Chiminski John RChair & CEOOct 07, 2019 Option Exercise$24.4047,5521,160,409348,387Oct 09, 2019, 01:13 PM
Chiminski John RChair & CEOOct 07, 2019 Sale$48.8497,0434,739,580224,257Oct 09, 2019, 01:13 PM
LUCIER GREGORY TDirectorSep 09, 2019 Buy$51.642,000103,28038,921Sep 11, 2019, 08:30 AM
Maselli AlessandroPresident & COOSep 09, 2019 Option Exercise$52.483,299173,13220,070Sep 11, 2019, 08:19 AM
Schmidt Kay ASVP, Technical OperationsAug 22, 2019 Option Exercise$55.241,15363,69212,002Aug 26, 2019, 03:51 PM
Pravda RicardoSVP, Human ResourcesAug 22, 2019 Option Exercise$55.241,21867,28213,458Aug 26, 2019, 03:50 PM
Maselli AlessandroPresident & COOAug 22, 2019 Option Exercise$55.245,466301,94223,369Aug 26, 2019, 03:50 PM
Littlejohns BarryPresident, Biologics & SDDAug 22, 2019 Option Exercise$55.247,178396,51345,882Aug 26, 2019, 03:49 PM
Kreuzburg ChristaDirectorAug 23, 2019 Option Exercise$53.151,25566,7036,930Aug 26, 2019, 03:49 PM
Joseph WettenySVP & Chief Financial OfficerAug 22, 2019 Option Exercise$55.244,176230,68246,427Aug 26, 2019, 03:48 PM
HEGWOOD PAUL W JRPresident, CSSAug 22, 2019 Option Exercise$55.241,06959,05211,848Aug 26, 2019, 03:48 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 22, 2019 Option Exercise$55.241,31772,75115,946Aug 26, 2019, 03:48 PM
Gennadios AristipposPresident, Softgel Tech.Aug 22, 2019 Option Exercise$55.243,805210,18844,232Aug 26, 2019, 03:47 PM
Fasman Steven LSVP & General CounselAug 22, 2019 Option Exercise$55.248,921492,79662,628Aug 26, 2019, 03:47 PM
Chiminski John RChair & CEOAug 22, 2019 Option Exercise$55.2451,7672,859,609307,837Aug 26, 2019, 03:45 PM
Arnold JonathanPresident, Oral Drug DeliveryAug 22, 2019 Option Exercise$55.242,765152,73934,245Aug 26, 2019, 03:44 PM
Schmidt Kay ASVP, Technical OperationsJul 26, 2019 Option Exercise$57.261,07961,7849,558Jul 30, 2019, 04:22 PM
Pravda RicardoSVP, Human ResourcesJul 26, 2019 Option Exercise$57.261,49885,77511,123Jul 30, 2019, 04:22 PM
Maselli AlessandroPresident & COOJul 26, 2019 Option Exercise$57.2698456,34417,209Jul 30, 2019, 04:22 PM
Littlejohns BarryPresident, Biologics & SDDJul 26, 2019 Option Exercise$57.261,23470,65938,487Jul 30, 2019, 04:21 PM
Joseph WettenySVP & Chief Financial OfficerJul 26, 2019 Option Exercise$57.2695454,62639,342Jul 30, 2019, 04:21 PM
HEGWOOD PAUL W JRPresident, CSSJul 26, 2019 Option Exercise$57.261,31875,4699,180Jul 30, 2019, 04:21 PM
Gunther ScottSVP, Quality & Reg. AffairsJul 26, 2019 Option Exercise$57.261,62693,10513,419Jul 30, 2019, 04:20 PM
Gennadios AristipposPresident, Softgel Tech.Jul 26, 2019 Option Exercise$57.2674842,83035,617Jul 30, 2019, 04:20 PM
Fasman Steven LSVP & General CounselJul 26, 2019 Option Exercise$57.262,205126,25853,332Jul 30, 2019, 04:20 PM
Chiminski John RChair & CEOJul 26, 2019 Option Exercise$57.2613,333763,448240,384Jul 30, 2019, 04:19 PM
Arnold JonathanPresident, Oral Drug DeliveryJul 26, 2019 Option Exercise$57.262,394137,08028,000Jul 30, 2019, 04:19 PM
CARROLL J MARTINDirectorJul 15, 2019 Option Exercise$53.244,927262,3134,927Jul 17, 2019, 06:53 PM
CARROLL J MARTINDirectorJul 15, 2019 Option Exercise$53.244,927262,3130Jul 17, 2019, 06:53 PM
Littlejohns BarryPresident, Biologics & SDDJul 12, 2019 Option Exercise$53.5433,2721,781,38353,658Jul 16, 2019, 07:21 PM
Littlejohns BarryPresident, Biologics & SDDJul 12, 2019 Option Exercise$19.3649,212952,93867,562Jul 16, 2019, 07:21 PM
Littlejohns BarryPresident, Biologics & SDDJul 12, 2019 Sale$53.5315,940853,34437,818Jul 16, 2019, 07:21 PM
Fasman Steven LSVP & General CounselJul 11, 2019 Option Exercise$54.0119,0401,028,35052,581Jul 15, 2019, 06:03 PM
Fasman Steven LSVP & General CounselJul 11, 2019 Option Exercise$27.3027,146741,14260,705Jul 15, 2019, 06:03 PM
Fasman Steven LSVP & General CounselJul 11, 2019 Sale$54.044,053219,02448,528Jul 15, 2019, 06:03 PM
BUZY PETER LPresident, Gene TherapyMay 29, 2019 Buy$45.1344,5002,008,28544,500May 30, 2019, 07:36 PM
Joseph WettenySVP & Chief Financial OfficerMay 28, 2019 Option Exercise$46.234,677216,21837,383May 30, 2019, 06:54 PM
Joseph WettenySVP & Chief Financial OfficerMay 28, 2019 Option Exercise$10.719,453101,24242,060May 30, 2019, 06:54 PM
MOREL DONALD E JRDirectorMay 15, 2019 Buy$44.4410,000444,40046,958May 16, 2019, 07:51 PM
LUCIER GREGORY TDirectorMay 09, 2019 Buy$45.082,00090,16038,822May 13, 2019, 01:39 PM
Gennadios AristipposPresident, Softgel Tech.Mar 21, 2019 Option Exercise$42.176,744284,38539,068Mar 25, 2019, 05:50 PM
Gennadios AristipposPresident, Softgel Tech.Mar 21, 2019 Option Exercise$10.7113,528144,88544,862Mar 25, 2019, 05:50 PM
Gennadios AristipposPresident, Softgel Tech.Mar 21, 2019 Sale$42.183,392143,08934,792Mar 25, 2019, 05:50 PM
Miyamoto LanceSVP, Human ResourcesMar 07, 2019 Option Exercise$42.6479,9913,410,81690,418Mar 11, 2019, 07:31 PM
Miyamoto LanceSVP, Human ResourcesMar 07, 2019 Option Exercise$15.34123,6101,896,336130,793Mar 11, 2019, 07:31 PM
Miyamoto LanceSVP, Human ResourcesMar 07, 2019 Sale$42.4943,6191,853,37946,918Mar 11, 2019, 07:31 PM
Kreuzburg ChristaDirectorFeb 16, 2019 Option Exercise$42.0335815,0475,018Feb 20, 2019, 03:53 PM
Downie WilliamSVP, Global Sales & MarketingFeb 15, 2019 Option Exercise$42.009,736408,91242,241Feb 20, 2019, 03:48 PM
Downie WilliamSVP, Global Sales & MarketingFeb 15, 2019 Option Exercise$24.6912,457307,50545,231Feb 20, 2019, 03:48 PM
Downie WilliamSVP, Global Sales & MarketingFeb 15, 2019 Sale$42.007,315307,23034,926Feb 20, 2019, 03:48 PM
Fasman Steven LSVP & General CounselJan 28, 2019 Option Exercise$36.495,199189,71244,475Jan 30, 2019, 01:29 PM
GREISCH JOHN JDirectorNov 08, 2018 Buy$37.6113,000488,93013,000Nov 13, 2018, 08:28 AM
Miyamoto LanceSVP, Human ResourcesOct 16, 2018 Option Exercise$42.5011,475487,68853,324Oct 18, 2018, 11:59 AM
Miyamoto LanceSVP, Human ResourcesOct 16, 2018 Option Exercise$12.1418,000218,52064,799Oct 18, 2018, 11:59 AM
Miyamoto LanceSVP, Human ResourcesOct 16, 2018 Sale$42.506,525277,31346,799Oct 18, 2018, 11:59 AM
Littlejohns BarryPresident, Biologics & SDDOct 15, 2018 Option Exercise$41.6497,5464,061,81584,983Oct 17, 2018, 12:28 PM
Littlejohns BarryPresident, Biologics & SDDOct 15, 2018 Option Exercise$14.86144,8112,151,891125,218Oct 17, 2018, 12:28 PM
Littlejohns BarryPresident, Biologics & SDDOct 15, 2018 Sale$41.6447,2651,968,11537,718Oct 17, 2018, 12:28 PM
Joseph WettenySVP & Chief Financial OfficerOct 15, 2018 Option Exercise$41.4730312,56532,607Oct 16, 2018, 03:55 PM
Chiminski John RChair, President & CEOOct 01, 2018 Option Exercise$45.32199,6089,046,234360,235Oct 03, 2018, 05:53 PM
Chiminski John RChair, President & CEOOct 01, 2018 Option Exercise$21.05286,3586,027,735416,074Oct 03, 2018, 05:53 PM
Chiminski John RChair, President & CEOOct 01, 2018 Sale$45.32130,5455,916,299229,690Oct 03, 2018, 05:53 PM
MOREL DONALD E JRDirectorSep 13, 2018 Buy$43.0010,000430,00036,958Sep 17, 2018, 10:56 AM
Miyamoto LanceSVP, Human ResourcesAug 27, 2018 Option Exercise$43.6698743,09246,799Sep 04, 2018, 07:53 PM
Maselli AlessandroSVP, Global OperationsAug 27, 2018 Option Exercise$43.6642718,64315,644Sep 04, 2018, 07:53 PM
Littlejohns BarryPresident, Biologics & SDDAug 27, 2018 Option Exercise$43.6694441,21537,718Sep 04, 2018, 07:52 PM
Joseph WettenySVP & Chief Financial OfficerAug 27, 2018 Option Exercise$43.6650221,91732,910Sep 04, 2018, 07:51 PM
HEGWOOD PAUL W JRPresident, CSSAug 27, 2018 Option Exercise$43.6650522,0489,587Sep 04, 2018, 07:51 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 27, 2018 Option Exercise$43.6659025,75913,807Sep 04, 2018, 07:50 PM
Fasman Steven LSVP & General CounselAug 27, 2018 Option Exercise$43.661,06346,41149,674Sep 04, 2018, 07:50 PM
Downie WilliamSVP, Global Sales & MarketingAug 27, 2018 Option Exercise$43.661,29156,36539,520Sep 04, 2018, 07:49 PM
Chiminski John RChair, President & CEOAug 27, 2018 Option Exercise$43.669,783427,126278,353Sep 04, 2018, 07:48 PM
Arnold JonathanPresident, Oral Drug DeliveryAug 27, 2018 Option Exercise$43.6651822,61632,696Sep 04, 2018, 07:48 PM
Miyamoto LanceSVP, Human ResourcesAug 27, 2018 Option Exercise$43.6698743,09248,773Aug 29, 2018, 04:51 PM
Maselli AlessandroSVP, Global OperationsAug 27, 2018 Option Exercise$43.6642718,64316,498Aug 29, 2018, 04:51 PM
Littlejohns BarryPresident, Biologics & SDDAug 27, 2018 Option Exercise$43.6694441,21539,606Aug 29, 2018, 04:50 PM
Joseph WettenySVP & Chief Financial OfficerAug 27, 2018 Option Exercise$43.6650221,91733,914Aug 29, 2018, 04:49 PM
HEGWOOD PAUL W JRPresident, CSSAug 27, 2018 Option Exercise$43.6650522,04810,597Aug 29, 2018, 04:49 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 27, 2018 Option Exercise$43.6659025,75914,987Aug 29, 2018, 04:48 PM
Fasman Steven LSVP & General CounselAug 27, 2018 Option Exercise$43.661,06346,41151,800Aug 29, 2018, 04:48 PM
Downie WilliamSVP, Global Sales & MarketingAug 27, 2018 Option Exercise$43.661,29156,36542,102Aug 29, 2018, 04:47 PM
Chiminski John RChair, President & CEOAug 27, 2018 Option Exercise$43.669,783427,126297,919Aug 29, 2018, 04:46 PM
Arnold JonathanPresident, Oral Drug DeliveryAug 27, 2018 Option Exercise$43.6651822,61633,732Aug 29, 2018, 04:46 PM
Miyamoto LanceSVP, Human ResourcesAug 23, 2018 Option Exercise$41.832,12989,05647,786Aug 27, 2018, 05:25 PM
Maselli AlessandroSVP, Global OperationsAug 23, 2018 Option Exercise$41.8336915,43516,071Aug 27, 2018, 05:24 PM
Littlejohns BarryPresident, Biologics & SDDAug 23, 2018 Option Exercise$41.832,03785,20838,662Aug 27, 2018, 05:23 PM
Joseph WettenySVP & Chief Financial OfficerAug 23, 2018 Option Exercise$41.831,83576,75833,412Aug 27, 2018, 05:23 PM
HEGWOOD PAUL W JRPresident, CSSAug 23, 2018 Option Exercise$41.8343518,19610,092Aug 27, 2018, 05:22 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 23, 2018 Option Exercise$41.8351121,37514,397Aug 27, 2018, 05:22 PM
Fasman Steven LSVP & General CounselAug 23, 2018 Option Exercise$41.832,29596,00050,737Aug 27, 2018, 05:20 PM
Downie WilliamSVP, Global Sales & MarketingAug 23, 2018 Option Exercise$41.832,787116,58040,811Aug 27, 2018, 05:20 PM
Chiminski John RChair, President & CEOAug 23, 2018 Option Exercise$41.8317,561734,577288,136Aug 27, 2018, 05:19 PM
Arnold JonathanPresident, Oral Drug DeliveryAug 23, 2018 Option Exercise$41.831,11746,72433,214Aug 27, 2018, 05:19 PM
Fasman Steven LSVP & General CounselJun 20, 2018 Option Exercise$41.7810,954457,65845,568Jun 21, 2018, 12:46 PM
Fasman Steven LSVP & General CounselJun 20, 2018 Option Exercise$24.2615,458375,01156,522Jun 21, 2018, 12:46 PM
Fasman Steven LSVP & General CounselJun 20, 2018 Sale$41.782,25294,08943,316Jun 21, 2018, 12:46 PM
Downie WilliamSVP, Global Sales & MarketingMar 08, 2018 Option Exercise$40.9512,965530,91744,475Mar 12, 2018, 11:44 AM
Downie WilliamSVP, Global Sales & MarketingMar 08, 2018 Option Exercise$26.1215,515405,23949,188Mar 12, 2018, 11:44 AM
Downie WilliamSVP, Global Sales & MarketingMar 08, 2018 Sale$41.809,082379,62835,393Mar 12, 2018, 11:44 AM
Chiminski John RChair, President & CEODec 11, 2017 Option Exercise$39.70125,2274,971,512411,539Dec 13, 2017, 02:37 PM
Chiminski John RChair, President & CEODec 11, 2017 Option Exercise$10.71206,6852,213,596536,766Dec 13, 2017, 02:37 PM
Chiminski John RChair, President & CEODec 12, 2017 Sale$39.5178,1903,089,287230,081Dec 13, 2017, 02:37 PM
Chiminski John RChair, President & CEODec 11, 2017 Sale$39.70103,2684,099,740330,081Dec 13, 2017, 02:37 PM
Roehrhoff UweDirectorNov 21, 2017 Buy$39.227,500294,15016,489Nov 22, 2017, 04:25 PM
Fasman Steven LSVP & General CounselOct 23, 2017 Option Exercise$42.741,60268,46936,064Oct 25, 2017, 12:32 PM
Chiminski John RChair, President & CEOOct 23, 2017 Option Exercise$42.743,604154,035330,081Oct 25, 2017, 12:32 PM
Chiminski John RChair, President & CEOSep 16, 2017 Option Exercise$39.4922,039870,320333,685Sep 18, 2017, 07:53 PM
Miyamoto LanceSVP - Human ResourcesAug 29, 2017 Option Exercise$38.2223,342892,13149,593Aug 31, 2017, 03:43 PM
Miyamoto LanceSVP - Human ResourcesAug 29, 2017 Option Exercise$12.1439,138475,13560,935Aug 31, 2017, 03:43 PM
Miyamoto LanceSVP - Human ResourcesAug 29, 2017 Sale$38.228,512325,32941,081Aug 31, 2017, 03:43 PM
Dolan ChristineSVP - Product DevelopmentAug 29, 2017 Option Exercise$38.755,964231,10521,043Aug 31, 2017, 10:41 AM
Dolan ChristineSVP - Product DevelopmentAug 29, 2017 Option Exercise$18.579,150169,91527,007Aug 31, 2017, 10:41 AM
Dolan ChristineSVP - Product DevelopmentAug 29, 2017 Sale$38.751,59461,76819,449Aug 31, 2017, 10:41 AM
WALSH MATTHEW MEVP & Chief Financial OfficerAug 24, 2017 Option Exercise$35.218,245290,306103,703Aug 28, 2017, 12:29 PM
Miyamoto LanceSVP - Human ResourcesAug 24, 2017 Option Exercise$35.213,604126,89733,797Aug 28, 2017, 12:29 PM
Maselli AlessandroSVP - Global OperationsAug 24, 2017 Option Exercise$35.2171825,28113,603Aug 28, 2017, 12:29 PM
Littlejohns BarryPresident - DDSAug 24, 2017 Option Exercise$35.213,400119,71432,249Aug 28, 2017, 12:28 PM
Joseph WettenyPresident - CSSAug 24, 2017 Option Exercise$35.211,82264,15314,277Aug 28, 2017, 12:28 PM
Gunther ScottSVP, Quality & Reg. AffairsAug 24, 2017 Option Exercise$35.2186930,59711,870Aug 28, 2017, 12:28 PM
Gennadios AristipposSee RemarksAug 24, 2017 Option Exercise$35.212,63392,70822,525Aug 28, 2017, 12:27 PM
Fasman Steven LSee RemarksAug 24, 2017 Option Exercise$35.213,828134,78437,666Aug 28, 2017, 12:27 PM
Downie WilliamSVP, Global Sales & MarketingAug 24, 2017 Option Exercise$35.215,644198,72541,925Aug 28, 2017, 12:27 PM
Dolan ChristineSVP - Product DevelopmentAug 24, 2017 Option Exercise$35.211,88166,23017,857Aug 28, 2017, 12:26 PM
Chiminski John RPresident & CEOAug 24, 2017 Option Exercise$35.2119,472685,609355,724Aug 28, 2017, 12:26 PM
Dolan ChristineSVP - Product DevelopmentAug 01, 2017 Sale$34.8574525,96314,058Aug 03, 2017, 05:31 PM
WALSH MATTHEW MEVP & Chief Financial OfficerJul 31, 2017 Option Exercise$34.973,230112,95395,757Aug 01, 2017, 06:35 PM
Miyamoto LanceSVP - Human ResourcesJul 31, 2017 Option Exercise$34.971,41249,37826,441Aug 01, 2017, 06:35 PM
Maselli AlessandroSVP - Global OperationsJul 31, 2017 Option Exercise$34.9770324,58412,802Aug 01, 2017, 06:35 PM
Littlejohns BarryPresident - DDSJul 31, 2017 Option Exercise$34.971,33246,58025,311Aug 01, 2017, 06:34 PM
Joseph WettenyPresident - CSSJul 31, 2017 Option Exercise$34.9771224,89910,558Aug 01, 2017, 06:34 PM
Gunther ScottSVP, Quality & Reg. AffairsJul 31, 2017 Option Exercise$34.9784529,55010,098Aug 01, 2017, 06:34 PM
Downie WilliamSVP, Global Sales & MarketingJul 31, 2017 Option Exercise$34.972,21177,31937,231Aug 01, 2017, 06:34 PM
Dolan ChristineSVP - Product DevelopmentJul 31, 2017 Option Exercise$34.9773425,66814,803Aug 01, 2017, 06:33 PM
Chiminski John RPresident & CEOJul 31, 2017 Option Exercise$34.973,816133,446321,274Aug 01, 2017, 06:33 PM
WALSH MATTHEW MSee RemarksJun 08, 2017 Option Exercise$37.0146,9031,735,814121,460Jun 12, 2017, 04:36 PM
WALSH MATTHEW MSee RemarksJun 08, 2017 Option Exercise$11.8474,651884,064168,363Jun 12, 2017, 04:36 PM
Johnson SharonSee RemarksApr 25, 2017 Option Exercise$29.0052,3921,519,36832,929Apr 27, 2017, 11:02 AM
Johnson SharonSee RemarksApr 25, 2017 Option Exercise$14.8270,7161,047,66853,670Apr 27, 2017, 11:02 AM
Johnson SharonSee RemarksApr 25, 2017 Sale$29.009,160265,64030,829Apr 27, 2017, 11:02 AM
Downie WilliamSee RemarksMar 20, 2017 Option Exercise$28.6341,5781,190,39840,731Mar 22, 2017, 07:06 PM
Downie WilliamSee RemarksMar 20, 2017 Option Exercise$13.2758,103770,99464,147Mar 22, 2017, 07:06 PM
Downie WilliamSee RemarksMar 20, 2017 Sale$28.608,262236,29336,665Mar 22, 2017, 07:06 PM
Chiminski John RSee RemarksMar 16, 2017 Option Exercise$28.50132,8653,786,653260,326Mar 20, 2017, 05:31 PM
Chiminski John RSee RemarksMar 16, 2017 Option Exercise$10.71206,6842,213,586393,191Mar 20, 2017, 05:31 PM
Chiminski John RSee RemarksMar 16, 2017 Sale$28.6273,6182,106,756191,492Mar 20, 2017, 05:31 PM
Chiminski John RSee RemarksMar 20, 2017 Sale$28.762015,781186,507Mar 20, 2017, 05:31 PM
MOREL DONALD E JRDirectorFeb 15, 2017 Buy$29.2710,000292,70018,799Feb 16, 2017, 04:42 PM
Blackstone Management Associates V L.L.C.10% OwnerSep 09, 2016 Sale$23.5817,100,705403,234,6230Sep 13, 2016, 06:07 PM
Blackstone Management Associates V L.L.C.10% OwnerJun 09, 2016 Sale$24.518,785,539215,333,56317,100,705Jun 13, 2016, 05:00 PM
WALSH MATTHEW MSee RemarksMay 27, 2016 Option Exercise$28.8567,9271,959,694101,443Jun 01, 2016, 05:35 PM
WALSH MATTHEW MSee RemarksMay 27, 2016 Option Exercise$15.6989,1241,398,010140,688Jun 01, 2016, 05:35 PM
WALSH MATTHEW MSee RemarksMay 27, 2016 Sale$28.8521,197611,53388,188Jun 01, 2016, 05:35 PM
CARROLL J MARTINDirectorSep 04, 2015 Option Exercise$27.263,00081,7806,928Sep 09, 2015, 02:50 PM
Chiminski John RSee RemarksAug 17, 2015 Option Exercise$33.8061,4952,078,531378,623Aug 19, 2015, 06:02 PM
Chiminski John RSee RemarksAug 17, 2015 Option Exercise$10.71100,0001,071,000440,118Aug 19, 2015, 06:02 PM
Chiminski John RSee RemarksAug 19, 2015 Sale$33.932,955100,263340,118Aug 19, 2015, 06:02 PM
Chiminski John RSee RemarksAug 17, 2015 Sale$33.8035,5501,201,590343,073Aug 19, 2015, 06:02 PM
Chiminski John RSee RemarksAug 03, 2015 Option Exercise$33.8564,7232,190,873375,395Aug 05, 2015, 04:28 PM
Chiminski John RSee RemarksAug 03, 2015 Option Exercise$10.71100,0001,071,000440,118Aug 05, 2015, 04:28 PM
Chiminski John RSee RemarksAug 03, 2015 Sale$33.8535,2771,194,126340,118Aug 05, 2015, 04:28 PM
WALSH MATTHEW MSee RemarksJul 27, 2015 Option Exercise$30.5057,5451,755,12399,740Jul 29, 2015, 01:58 PM
WALSH MATTHEW MSee RemarksJul 27, 2015 Option Exercise$11.5084,717974,229130,880Jul 29, 2015, 01:58 PM
WALSH MATTHEW MSee RemarksJul 27, 2015 Sale$31.1827,172847,22384,120Jul 29, 2015, 01:58 PM
Chiminski John RSee RemarksJul 20, 2015 Option Exercise$29.4066,9191,967,419359,140Jul 22, 2015, 01:54 PM
Chiminski John RSee RemarksJul 20, 2015 Option Exercise$10.71100,0001,071,000397,618Jul 22, 2015, 01:54 PM
Chiminski John RSee RemarksJul 20, 2015 Sale$29.4033,081972,581340,118Jul 22, 2015, 01:54 PM
Chiminski John RSee RemarksJul 06, 2015 Option Exercise$29.3466,1721,941,486373,946Jul 08, 2015, 08:42 AM
Chiminski John RSee RemarksJul 06, 2015 Option Exercise$10.71100,0001,071,000440,118Jul 08, 2015, 08:42 AM
Chiminski John RSee RemarksJul 06, 2015 Sale$29.3433,828992,514340,118Jul 08, 2015, 08:42 AM
Blackstone Management Associates V L.L.C.10% OwnerJun 11, 2015 Sale$28.131,844,96351,898,80825,886,244Jun 11, 2015, 05:00 PM
Blackstone Management Associates V L.L.C.10% OwnerJun 08, 2015 Sale$28.1312,299,753345,992,04227,731,207Jun 10, 2015, 05:00 PM
WALSH MATTHEW MSee RemarksApr 06, 2015 Option Exercise$30.4367,9872,068,844116,559Apr 08, 2015, 11:08 AM
WALSH MATTHEW MSee RemarksApr 06, 2015 Option Exercise$10.71102,0431,092,881184,546Apr 08, 2015, 11:08 AM
WALSH MATTHEW MSee RemarksApr 06, 2015 Sale$30.4334,4391,047,97984,120Apr 08, 2015, 11:08 AM
Houlton ScottSee RemarksApr 01, 2015 Option Exercise$30.6165,9362,018,30137,973Apr 03, 2015, 05:29 PM
Houlton ScottSee RemarksApr 01, 2015 Option Exercise$11.9898,0351,174,87074,571Apr 03, 2015, 05:29 PM
Houlton ScottSee RemarksApr 01, 2015 Sale$30.6116,253497,50434,127Apr 03, 2015, 05:29 PM
Gennadios AristipposSee RemarksApr 01, 2015 Option Exercise$30.6139,8611,220,14521,734Apr 03, 2015, 05:00 PM
Gennadios AristipposSee RemarksApr 01, 2015 Option Exercise$11.2265,464734,57338,961Apr 03, 2015, 05:00 PM
Gennadios AristipposSee RemarksApr 01, 2015 Sale$30.6124,868761,2098,651Apr 03, 2015, 05:00 PM
WALSH MATTHEW MSee RemarksMar 27, 2015 Option Exercise$30.1011,039332,27484,503Mar 31, 2015, 06:23 PM
Leonard StephenSee RemarksMar 27, 2015 Option Exercise$30.1383,7142,522,30375,536Mar 31, 2015, 06:11 PM
Leonard StephenSee RemarksMar 27, 2015 Option Exercise$10.71136,0001,456,560159,250Mar 31, 2015, 06:11 PM
Leonard StephenSee RemarksMar 27, 2015 Sale$30.1331,005934,18144,531Mar 31, 2015, 06:11 PM
Johnson SharonSee RemarksFeb 13, 2015 Option Exercise$27.8333,300926,73925,523Feb 19, 2015, 08:14 PM
Johnson SharonSee RemarksFeb 17, 2015 Option Exercise$27.4053,1691,456,83139,596Feb 19, 2015, 08:14 PM
Johnson SharonSee RemarksFeb 17, 2015 Option Exercise$11.0077,852856,69190,383Feb 19, 2015, 08:14 PM
Johnson SharonSee RemarksFeb 13, 2015 Option Exercise$10.7149,400529,07446,473Feb 19, 2015, 08:14 PM
Johnson SharonSee RemarksFeb 13, 2015 Sale$27.8216,100447,96215,393Feb 19, 2015, 08:14 PM
Johnson SharonSee RemarksFeb 17, 2015 Sale$27.4024,683676,31415,393Feb 19, 2015, 08:14 PM
Kurt NielsenSee RemarksFeb 17, 2015 Option Exercise$27.4142,4291,162,97952,767Feb 19, 2015, 07:28 PM
Kurt NielsenSee RemarksFeb 17, 2015 Option Exercise$10.7171,520765,97995,196Feb 19, 2015, 07:28 PM
Kurt NielsenSee RemarksFeb 17, 2015 Sale$27.4129,091797,38423,676Feb 19, 2015, 07:28 PM
Kurt NielsenSee RemarksFeb 17, 2015 Option Exercise$27.4128,040768,57643,676Feb 19, 2015, 09:39 AM
Kurt NielsenSee RemarksFeb 17, 2015 Option Exercise$10.7148,040514,50871,716Feb 19, 2015, 09:39 AM
Kurt NielsenSee RemarksFeb 17, 2015 Sale$27.4120,000548,20023,676Feb 19, 2015, 09:39 AM
Houlton ScottSee RemarksFeb 13, 2015 Option Exercise$28.281,89353,53420Feb 18, 2015, 09:28 PM
Houlton ScottSee RemarksFeb 17, 2015 Option Exercise$27.421849431,419Feb 18, 2015, 09:28 PM
Houlton ScottSee RemarksFeb 13, 2015 Option Exercise$10.713,29335,26821,574Feb 18, 2015, 09:28 PM
Houlton ScottSee RemarksFeb 17, 2015 Option Exercise$10.7131,210334,25949,491Feb 18, 2015, 09:28 PM
Houlton ScottSee RemarksFeb 13, 2015 Sale$28.281,40039,59218,281Feb 18, 2015, 09:28 PM
Houlton ScottSee RemarksFeb 17, 2015 Sale$27.4213,138360,24418,281Feb 18, 2015, 09:28 PM
Leonard StephenSee RemarksFeb 13, 2015 Option Exercise$28.341,50842,73724,250Feb 18, 2015, 09:01 PM
Leonard StephenSee RemarksFeb 13, 2015 Option Exercise$10.712,50826,86125,758Feb 18, 2015, 09:01 PM
Leonard StephenSee RemarksFeb 13, 2015 Sale$28.341,00028,34023,250Feb 18, 2015, 09:01 PM
Downie WilliamSee RemarksFeb 13, 2015 Option Exercise$27.865,122142,69923,351Feb 18, 2015, 08:39 PM
Downie WilliamSee RemarksFeb 17, 2015 Option Exercise$27.8293,9692,614,21855,866Feb 18, 2015, 08:39 PM
Downie WilliamSee RemarksFeb 13, 2015 Option Exercise$10.716,20266,42328,473Feb 18, 2015, 08:39 PM
Downie WilliamSee RemarksFeb 17, 2015 Option Exercise$10.71138,9691,488,358126,240Feb 18, 2015, 08:39 PM
Downie WilliamSee RemarksFeb 13, 2015 Sale$27.861,08030,08922,271Feb 18, 2015, 08:39 PM
Downie WilliamSee RemarksFeb 17, 2015 Sale$27.8245,0001,251,90022,271Feb 18, 2015, 08:39 PM
WALSH MATTHEW MSee RemarksFeb 13, 2015 Sale$28.113,20089,95295,542Feb 18, 2015, 06:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hopson RickyPres. BioProduct Delivery, CoS06/04/202476,023
Gunther ScottSVP, Quality & Reg. Affairs03/15/202421,749
Kreuzburg ChristaDirector01/25/202426,364
Gennadios AristipposGroup Pres. Pharma & Consumer12/08/202313,645
Maselli AlessandroPresident & CEO12/08/202371,534
Gunther ScottSVP, Quality & Reg. Affairs12/08/20239,295
Hopson RickyPres. Clinical Dev Supply Div12/08/20239,518
Kreuzburg ChristaDirector10/27/202348,953
Hunt PatriciaPres. Consumer Health Div10/16/20231,023
Ryan Michelle RDirector08/31/202349,980
GREISCH JOHN JExecutive Chair08/30/20231,055,040
Maselli AlessandroPresident & CEO08/24/202392,245
Gunther ScottSVP, Quality & Reg. Affairs08/24/202311,989
Grippo Michael JSVP, Strategy & Corp. Dev.08/24/202317,355
Gennadios AristipposGroup Pres. Pharma & Consumer08/24/202317,618
Fasman Steven LEVP & Chief Admin Officer08/24/202336,479
Carletti LorenzoSVP Global Ops Ph & Cons Hlth08/24/20239,657
Arnold JonathanSVP, CCO & Div. Head BioP Del.08/24/20233,904
Hopson RickyPres. Clinical Dev Supply Div08/24/202312,299
Hawkeswood Thomas WPres. Pharma Prod Delivery Div08/24/20236,574
Lickfold CharlesSVP, CIO08/24/20238,497
Hunt PatriciaPres. Consumer Health Div08/24/20234,746
Pravda RicardoChief Transformation Officer08/24/202316,854
Pravda RicardoChief Transformation Officer08/01/202312,793
Maselli AlessandroPresident & CEO08/01/202369,995
Lickfold CharlesSVP, CIO08/01/20236,467
Hunt PatriciaPres. Consumer Health Div08/01/20237,720
Hopson RickyPres. Clinical Dev Supply Div08/01/20239,333
Hawkeswood Thomas WPres. Pharma Prod Delivery Div08/01/202312,376
Gunther ScottSVP, Quality & Reg. Affairs08/01/20239,101
Grippo Michael JSVP, Strategy & Corp. Dev.08/01/202313,171
Gennadios AristipposGroup Pres. Pharma & Consumer08/01/202313,373
Carletti LorenzoSVP Global Ops Ph & Cons Hlth08/01/202318,296
Arnold JonathanSVP, CCO & Div. Head BioP Del.08/01/20232,964
Fasman Steven LEVP & Chief Admin Officer08/01/202377,026
Boerman ManjaPres. BioModalities Division05/01/202372,098
Gargiulo MarioSVP, Ops, Biologics Europe05/01/202333,805
Hopson RickyPres. Clinical Dev Supply Div01/23/202331,738
Boerman ManjaPres. BioModalities Division12/05/202240,326
Grippo Michael JSVP, Strategy & Corp. Dev.10/31/2022161,349
Kreuzburg ChristaDirector10/27/202227,900
Hawkeswood Thomas WPres. Pharma Prod Delivery Div10/10/202272,038
Hopson RickyPres. Clinical Dev Supply Div08/31/2022198,531
Riley Michael A.Pres. Bio Product Delivery Div08/26/2022259,238
Gunther ScottSVP, Quality & Reg. Affairs08/26/2022170,571
Schmidt Kay ASVP, Enterprise Functions08/25/2022136,116
Riley Michael A.Pres. Bio Product Delivery Div08/25/2022152,705
Pravda RicardoSVP & Chief HR Officer08/25/2022180,011
Maselli AlessandroPresident & CEO08/25/2022478,724
Hunt PatriciaPres. Consumer Health Div08/25/202234,931
Hopson RickyPres. Clinical Dev Supply Div08/25/2022156,312
Hawkeswood Thomas WPres. Pharma Prod Delivery Div08/25/202269,140
Gunther ScottSVP, Quality & Reg. Affairs08/25/2022189,594
Grippo Michael JSVP, Strategy & Corp. Dev.08/25/2022172,077
Gennadios AristipposGroup Pres. Pharma & Consumer08/25/2022169,501
Gargiulo MarioSVP Global Ops Biologics08/25/2022163,421
Fasman Steven LEVP & Chief Admin Officer08/25/2022495,725
Chiminski John RExecutive Chair08/25/20224,011,759
Castellano Thomas PSVP, Chief Financial Officer08/25/2022145,699
Carletti LorenzoSVP Global Ops Ph & Cons Hlth08/25/2022106,440
Boerman ManjaPres. BioModalities Division08/25/2022339,620
Arnold JonathanSVP & Chief Commercial Ofcr08/25/202239,567
Schmidt Kay ASVP, Enterprise Functions07/26/202234,529
Pravda RicardoSVP & Chief HR Officer07/26/202245,646
Maselli AlessandroPresident & CEO07/26/202287,230
Hopson RickyPres, Clinical Dev & Supply07/27/202263,633
Hopson RickyPres, Clinical Dev & Supply07/26/202233,353
Gunther ScottSVP, Quality & Reg. Affairs07/27/202242,422
Gunther ScottSVP, Quality & Reg. Affairs07/26/202248,105
Grippo Michael JSVP, Strategy & Corp. Dev.07/27/202241,776
Grippo Michael JSVP, Strategy & Corp. Dev.07/26/202243,722
Gennadios AristipposGroup Pres. Pharma & Consumer07/26/202243,081
Gargiulo MarioSVP Global Ops Biologics07/26/2022103,586
Fasman Steven LEVP & Chief Admin Officer07/26/2022272,167
Chiminski John RExecutive Chair07/26/20221,035,968
Castellano Thomas PSVP, Chief Financial Officer07/26/202237,094
Carletti LorenzoSVP Global Ops Ph & Cons Hlth07/26/202267,454
Arnold JonathanSVP & Chief Commercial Ofcr07/26/202210,049
Gennadios AristipposGroup Pres. Pharma & Consumer07/01/20222,000,097
Arnold JonathanSVP & Chief Commercial Ofcr07/01/2022300,084
Gargiulo MarioSVP Global Ops Large Molecule06/10/202212,578
Fasman Steven LSVP & General Counsel06/10/2022535,352
Zippelius PeterDirector02/06/202249,999,995
Hopson RickyVP, Chief Accounting Officer01/31/2022240,382
Whitlow Ricci SPresident, CSS01/21/202218,836
Flynn KarenChief Commercial Officer01/10/2022288,334
Zippelius PeterDirector11/18/2021387,555,795
Zippelius PeterDirector11/30/2021387,900,009
CARROLL J MARTINDirector11/29/2021420,600
CARROLL J MARTINDirector11/29/2021420,600
LUCIER GREGORY TDirector11/23/2021645,407
Arnold JonathanPres. Oral & Specialty Deliv.11/01/2021338,421
Arnold JonathanPres. Oral & Specialty Deliv.11/01/20211,494,293
Kreuzburg ChristaDirector10/28/202186,449
Castellano Thomas PSVP, Chief Financial Officer10/20/2021309,138
Arnold JonathanPres. Oral & Specialty Deliv.10/14/2021214,950
Schmidt Kay ASVP, Technical Operations10/04/2021287,569
Fasman Steven LSVP & General Counsel10/04/2021889,050
Fasman Steven LSVP & General Counsel10/04/20214,479,975
Pravda RicardoSVP & Chief HR Officer10/01/2021241,694
Pravda RicardoSVP & Chief HR Officer10/01/2021650,928
Grippo Michael JSVP, Strategy & Corp. Dev.10/01/2021270,557
Chiminski John RChair & CEO10/01/20212,986,973
Chiminski John RChair & CEO10/01/202119,979,610
Kreuzburg ChristaDirector08/27/202125,840
Castellano Thomas PSVP, Chief Financial Officer08/27/2021274,458
Schmidt Kay ASVP, Technical Operations08/27/2021108,183
Hopson RickyVP, Chief Accounting Officer08/27/2021192,894
Pravda RicardoSVP & Chief HR Officer08/27/202190,742
Maselli AlessandroPresident & COO08/27/2021490,824
Gunther ScottSVP, Quality & Reg. Affairs08/27/2021545,725
Grippo Michael JSVP, Strategy & Corp. Dev.08/27/2021222,661
Gennadios AristipposPresident Softgel & Oral Tech08/27/2021296,619
Fasman Steven LSVP & General Counsel08/27/2021801,344
Chiminski John RChair & CEO08/27/20215,830,710
Arnold JonathanPres. Oral & Specialty Deliv.08/27/202159,271
Grippo Michael JSVP, Strategy & Corp. Dev.12/19/201999,684
Grippo Michael JSVP, Strategy & Corp. Dev.01/13/202097,440
Grippo Michael JSVP, Strategy & Corp. Dev.12/20/2019134,736
Castellano Thomas PSVP, Chief Financial Officer07/26/202162,743
Schmidt Kay ASVP, Technical Operations07/26/202161,838
Hopson RickyVP, Chief Accounting Officer07/26/202140,698
Pravda RicardoSVP & Chief HR Officer07/26/202151,777
Maselli AlessandroPresident & COO07/26/2021112,259
Gunther ScottSVP, Quality & Reg. Affairs07/26/2021121,967
Grippo Michael JSVP, Strategy & Corp. Dev.07/26/202150,986
Gennadios AristipposPresident Softgel & Oral Tech07/26/202152,568
Fasman Steven LSVP & General Counsel07/26/2021175,114
Chiminski John RChair & CEO07/26/20211,259,038
Arnold JonathanPres. Oral & Specialty Deliv.07/26/202113,566
Fasman Steven LSVP & General Counsel07/15/2021494,353
Pravda RicardoSVP & Chief HR Officer06/23/2021309,624
Schmidt Kay ASVP, Technical Operations03/22/2021148,078
Fasman Steven LSVP & General Counsel03/18/2021839,445
Fasman Steven LSVP & General Counsel03/18/20212,262,770
Chiminski John RChair & CEO03/19/20217,698,674
Chiminski John RChair & CEO03/18/20211,520,764
Chiminski John RChair & CEO03/19/202119,402,784
Chiminski John RChair & CEO03/18/20214,439,855
Joseph WettenySVP & Chief Financial Officer02/16/2021262,799
Joseph WettenySVP & Chief Financial Officer02/16/2021622,685
Joseph WettenySVP & Chief Financial Officer02/08/2021523,613
Whitlow Ricci SPresident, CSS01/21/202182,244
Flynn KarenPres. Biologics & CCO01/11/2021278,279
Gunther ScottSVP, Quality & Reg. Affairs01/06/20216,392
Whitlow Ricci SPresident, CSS01/04/20218,667
Schmidt Kay ASVP, Technical Operations01/04/20217,623
Pravda RicardoSVP & Chief HR Officer01/04/20218,145
Maselli AlessandroPresident & COO01/04/202115,454
Joseph WettenySVP & Chief Financial Officer01/04/202117,960
Gunther ScottSVP, Quality & Reg. Affairs01/04/202112,530
Grippo Michael JSVP, Strategy & Corp. Dev.01/04/202113,157
Gennadios AristipposPresident Softgel & Oral Tech01/04/202111,486
Flynn KarenPres. Biologics & CCO01/04/202110,338
Fasman Steven LSVP & General Counsel01/04/202119,735
Arnold JonathanPres. Oral & Specialty Deliv.01/04/20211,671
Gennadios AristipposPresident Softgel & Oral Tech12/21/2020446,526
Gennadios AristipposPresident Softgel & Oral Tech12/21/20201,405,044
Zippelius PeterDirector11/23/2020267,138,411
Zippelius PeterDirector11/23/2020535,237,724
Fasman Steven LSVP & General Counsel11/11/2020244,901
Schmidt Kay ASVP, Technical Operations10/23/202039,958
Schmidt Kay ASVP, Technical Operations10/14/2020278,045
Fasman Steven LSVP & General Counsel10/14/2020885,883
Fasman Steven LSVP & General Counsel10/14/2020393,426
Fasman Steven LSVP & General Counsel10/14/2020512,934
Grippo Michael JSVP, Strategy & Corp. Dev.10/12/2020159,583
Arnold JonathanPres. Oral & Specialty Deliv.10/07/20202,142,381
Arnold JonathanPres. Oral & Specialty Deliv.10/07/20201,213,364
Arnold JonathanPres. Oral & Specialty Deliv.10/07/20201,457,412
Arnold JonathanPres. Oral & Specialty Deliv.10/04/202020,611
Gunther ScottSVP, Quality & Reg. Affairs10/02/2020441,688
Gunther ScottSVP, Quality & Reg. Affairs10/02/2020264,639
Gunther ScottSVP, Quality & Reg. Affairs10/02/2020372,608
Chiminski John RChair & CEO10/02/20207,418,449
Chiminski John RChair & CEO10/02/20204,130,817
Chiminski John RChair & CEO10/02/202015,673,809
Grippo Michael JSVP, Strategy & Corp. Dev.09/02/2020201,378
Schmidt Kay ASVP, Technical Operations08/27/202079,290
Pravda RicardoSVP & Chief HR Officer08/27/202082,711
Maselli AlessandroPresident & COO08/27/2020369,873
Joseph WettenySVP & Chief Financial Officer08/27/2020305,231
Gunther ScottSVP, Quality & Reg. Affairs08/27/2020247,605
Grippo Michael JSVP, Strategy & Corp. Dev.08/27/2020209,802
Gennadios AristipposPresident Softgel & Oral Tech08/27/2020384,521
Fasman Steven LSVP & General Counsel08/27/2020585,552
Chiminski John RChair & CEO08/27/20205,172,960
Arnold JonathanPres. Oral & Specialty Deliv.08/27/2020265,147
Kreuzburg ChristaDirector08/22/202082,252
Chiminski John RChair & CEO08/23/2020402,092
LUCIER GREGORY TDirector07/30/20202,162,160
Schmidt Kay ASVP, Technical Operations07/24/202041,147
Pravda RicardoSVP & Chief HR Officer07/24/2020159,116
Maselli AlessandroPresident & COO07/24/202076,742
Joseph WettenySVP & Chief Financial Officer07/24/202062,128
Gunther ScottSVP, Quality & Reg. Affairs07/24/202052,739
Grippo Michael JSVP, Strategy & Corp. Dev.07/24/202043,432
Gennadios AristipposPresident Softgel & Oral Tech07/24/202080,334
Fasman Steven LSVP & General Counsel07/24/2020100,172
Chiminski John RChair & CEO07/24/2020542,253
Arnold JonathanPres. Oral & Specialty Deliv.07/24/2020309,905
Gunther ScottSVP, Quality & Reg. Affairs06/29/2020203,318
Gennadios AristipposPresident Softgel & Oral Tech06/25/20201,016,890
Gennadios AristipposPresident Softgel & Oral Tech06/25/2020622,541
Gennadios AristipposPresident Softgel & Oral Tech06/25/2020607,725
CARROLL J MARTINDirector05/12/2020260,244
CARROLL J MARTINDirector05/12/2020260,244
Whitlow Ricci SPresident, CSS04/09/202013,550
Schmidt Kay ASVP, Technical Operations04/09/202012,760
Pravda RicardoSVP & Chief HR Officer04/09/202012,760
Maselli AlessandroPresident & COO04/09/202017,785
Joseph WettenySVP & Chief Financial Officer04/09/202019,705
Gunther ScottSVP, Quality & Reg. Affairs04/09/202013,720
Grippo Michael JSVP, Strategy & Corp. Dev.04/09/202014,454
Gennadios AristipposPresident Softgel & Oral Tech04/09/202015,752
Flynn KarenPres. Biologics & CCO04/09/202020,269
Fasman Steven LSVP & General Counsel04/09/202021,794
BUZY PETER LPresident, Gene Therapy04/09/202015,018
Arnold JonathanPres. Oral & Specialty Deliv.04/09/202014,905
LUCIER GREGORY TDirector02/13/2020119,420
Schmidt Kay ASVP, Technical Operations02/02/202012,648
Maselli AlessandroPresident & COO12/16/2019386,512
Pravda RicardoSVP & Chief HR Officer11/26/2019137,718
Gennadios AristipposPresident Softgel & Oral Tech11/25/20194,131,218
Gennadios AristipposPresident Softgel & Oral Tech11/25/20192,272,760
Gennadios AristipposPresident Softgel & Oral Tech11/25/20192,378,203
Grippo Michael JSVP, Strategy & Corp. Dev.11/22/201919,552
Chiminski John RChair & CEO10/07/20191,664,907
Chiminski John RChair & CEO10/07/20191,160,409
Chiminski John RChair & CEO10/07/20194,739,580
LUCIER GREGORY TDirector09/09/2019103,280
Maselli AlessandroPresident & COO09/09/2019173,132
Schmidt Kay ASVP, Technical Operations08/22/201963,692
Pravda RicardoSVP, Human Resources08/22/201967,282
Maselli AlessandroPresident & COO08/22/2019301,942
Littlejohns BarryPresident, Biologics & SDD08/22/2019396,513
Kreuzburg ChristaDirector08/23/201966,703
Joseph WettenySVP & Chief Financial Officer08/22/2019230,682
HEGWOOD PAUL W JRPresident, CSS08/22/201959,052
Gunther ScottSVP, Quality & Reg. Affairs08/22/201972,751
Gennadios AristipposPresident, Softgel Tech.08/22/2019210,188
Fasman Steven LSVP & General Counsel08/22/2019492,796
Chiminski John RChair & CEO08/22/20192,859,609
Arnold JonathanPresident, Oral Drug Delivery08/22/2019152,739
Schmidt Kay ASVP, Technical Operations07/26/201961,784
Pravda RicardoSVP, Human Resources07/26/201985,775
Maselli AlessandroPresident & COO07/26/201956,344
Littlejohns BarryPresident, Biologics & SDD07/26/201970,659
Joseph WettenySVP & Chief Financial Officer07/26/201954,626
HEGWOOD PAUL W JRPresident, CSS07/26/201975,469
Gunther ScottSVP, Quality & Reg. Affairs07/26/201993,105
Gennadios AristipposPresident, Softgel Tech.07/26/201942,830
Fasman Steven LSVP & General Counsel07/26/2019126,258
Chiminski John RChair & CEO07/26/2019763,448
Arnold JonathanPresident, Oral Drug Delivery07/26/2019137,080
CARROLL J MARTINDirector07/15/2019262,313
CARROLL J MARTINDirector07/15/2019262,313
Littlejohns BarryPresident, Biologics & SDD07/12/20191,781,383
Littlejohns BarryPresident, Biologics & SDD07/12/2019952,938
Littlejohns BarryPresident, Biologics & SDD07/12/2019853,344
Fasman Steven LSVP & General Counsel07/11/20191,028,350
Fasman Steven LSVP & General Counsel07/11/2019741,142
Fasman Steven LSVP & General Counsel07/11/2019219,024
BUZY PETER LPresident, Gene Therapy05/29/20192,008,285
Joseph WettenySVP & Chief Financial Officer05/28/2019216,218
Joseph WettenySVP & Chief Financial Officer05/28/2019101,242
MOREL DONALD E JRDirector05/15/2019444,400
LUCIER GREGORY TDirector05/09/201990,160
Gennadios AristipposPresident, Softgel Tech.03/21/2019284,385
Gennadios AristipposPresident, Softgel Tech.03/21/2019144,885
Gennadios AristipposPresident, Softgel Tech.03/21/2019143,089
Miyamoto LanceSVP, Human Resources03/07/20193,410,816
Miyamoto LanceSVP, Human Resources03/07/20191,896,336
Miyamoto LanceSVP, Human Resources03/07/20191,853,379
Kreuzburg ChristaDirector02/16/201915,047
Downie WilliamSVP, Global Sales & Marketing02/15/2019408,912
Downie WilliamSVP, Global Sales & Marketing02/15/2019307,505
Downie WilliamSVP, Global Sales & Marketing02/15/2019307,230
Fasman Steven LSVP & General Counsel01/28/2019189,712
GREISCH JOHN JDirector11/08/2018488,930
Miyamoto LanceSVP, Human Resources10/16/2018487,688
Miyamoto LanceSVP, Human Resources10/16/2018218,520
Miyamoto LanceSVP, Human Resources10/16/2018277,313
Littlejohns BarryPresident, Biologics & SDD10/15/20184,061,815
Littlejohns BarryPresident, Biologics & SDD10/15/20182,151,891
Littlejohns BarryPresident, Biologics & SDD10/15/20181,968,115
Joseph WettenySVP & Chief Financial Officer10/15/201812,565
Chiminski John RChair, President & CEO10/01/20189,046,234
Chiminski John RChair, President & CEO10/01/20186,027,735
Chiminski John RChair, President & CEO10/01/20185,916,299
MOREL DONALD E JRDirector09/13/2018430,000
Miyamoto LanceSVP, Human Resources08/27/201843,092
Maselli AlessandroSVP, Global Operations08/27/201818,643
Littlejohns BarryPresident, Biologics & SDD08/27/201841,215
Joseph WettenySVP & Chief Financial Officer08/27/201821,917
HEGWOOD PAUL W JRPresident, CSS08/27/201822,048
Gunther ScottSVP, Quality & Reg. Affairs08/27/201825,759
Fasman Steven LSVP & General Counsel08/27/201846,411
Downie WilliamSVP, Global Sales & Marketing08/27/201856,365
Chiminski John RChair, President & CEO08/27/2018427,126
Arnold JonathanPresident, Oral Drug Delivery08/27/201822,616
Miyamoto LanceSVP, Human Resources08/27/201843,092
Maselli AlessandroSVP, Global Operations08/27/201818,643
Littlejohns BarryPresident, Biologics & SDD08/27/201841,215
Joseph WettenySVP & Chief Financial Officer08/27/201821,917
HEGWOOD PAUL W JRPresident, CSS08/27/201822,048
Gunther ScottSVP, Quality & Reg. Affairs08/27/201825,759
Fasman Steven LSVP & General Counsel08/27/201846,411
Downie WilliamSVP, Global Sales & Marketing08/27/201856,365
Chiminski John RChair, President & CEO08/27/2018427,126
Arnold JonathanPresident, Oral Drug Delivery08/27/201822,616
Miyamoto LanceSVP, Human Resources08/23/201889,056
Maselli AlessandroSVP, Global Operations08/23/201815,435
Littlejohns BarryPresident, Biologics & SDD08/23/201885,208
Joseph WettenySVP & Chief Financial Officer08/23/201876,758
HEGWOOD PAUL W JRPresident, CSS08/23/201818,196
Gunther ScottSVP, Quality & Reg. Affairs08/23/201821,375
Fasman Steven LSVP & General Counsel08/23/201896,000
Downie WilliamSVP, Global Sales & Marketing08/23/2018116,580
Chiminski John RChair, President & CEO08/23/2018734,577
Arnold JonathanPresident, Oral Drug Delivery08/23/201846,724
Fasman Steven LSVP & General Counsel06/20/2018457,658
Fasman Steven LSVP & General Counsel06/20/2018375,011
Fasman Steven LSVP & General Counsel06/20/201894,089
Downie WilliamSVP, Global Sales & Marketing03/08/2018530,917
Downie WilliamSVP, Global Sales & Marketing03/08/2018405,239
Downie WilliamSVP, Global Sales & Marketing03/08/2018379,628
Chiminski John RChair, President & CEO12/11/20174,971,512
Chiminski John RChair, President & CEO12/11/20172,213,596
Chiminski John RChair, President & CEO12/12/20173,089,287
Chiminski John RChair, President & CEO12/11/20174,099,740
Roehrhoff UweDirector11/21/2017294,150
Fasman Steven LSVP & General Counsel10/23/201768,469
Chiminski John RChair, President & CEO10/23/2017154,035
Chiminski John RChair, President & CEO09/16/2017870,320
Miyamoto LanceSVP - Human Resources08/29/2017892,131
Miyamoto LanceSVP - Human Resources08/29/2017475,135
Miyamoto LanceSVP - Human Resources08/29/2017325,329
Dolan ChristineSVP - Product Development08/29/2017231,105
Dolan ChristineSVP - Product Development08/29/2017169,915
Dolan ChristineSVP - Product Development08/29/201761,768
WALSH MATTHEW MEVP & Chief Financial Officer08/24/2017290,306
Miyamoto LanceSVP - Human Resources08/24/2017126,897
Maselli AlessandroSVP - Global Operations08/24/201725,281
Littlejohns BarryPresident - DDS08/24/2017119,714
Joseph WettenyPresident - CSS08/24/201764,153
Gunther ScottSVP, Quality & Reg. Affairs08/24/201730,597
Gennadios AristipposSee Remarks08/24/201792,708
Fasman Steven LSee Remarks08/24/2017134,784
Downie WilliamSVP, Global Sales & Marketing08/24/2017198,725
Dolan ChristineSVP - Product Development08/24/201766,230
Chiminski John RPresident & CEO08/24/2017685,609
Dolan ChristineSVP - Product Development08/01/201725,963
WALSH MATTHEW MEVP & Chief Financial Officer07/31/2017112,953
Miyamoto LanceSVP - Human Resources07/31/201749,378
Maselli AlessandroSVP - Global Operations07/31/201724,584
Littlejohns BarryPresident - DDS07/31/201746,580
Joseph WettenyPresident - CSS07/31/201724,899
Gunther ScottSVP, Quality & Reg. Affairs07/31/201729,550
Downie WilliamSVP, Global Sales & Marketing07/31/201777,319
Dolan ChristineSVP - Product Development07/31/201725,668
Chiminski John RPresident & CEO07/31/2017133,446
WALSH MATTHEW MSee Remarks06/08/20171,735,814
WALSH MATTHEW MSee Remarks06/08/2017884,064
Johnson SharonSee Remarks04/25/20171,519,368
Johnson SharonSee Remarks04/25/20171,047,668
Johnson SharonSee Remarks04/25/2017265,640
Downie WilliamSee Remarks03/20/20171,190,398
Downie WilliamSee Remarks03/20/2017770,994
Downie WilliamSee Remarks03/20/2017236,293
Chiminski John RSee Remarks03/16/20173,786,653
Chiminski John RSee Remarks03/16/20172,213,586
Chiminski John RSee Remarks03/16/20172,106,756
Chiminski John RSee Remarks03/20/20175,781
MOREL DONALD E JRDirector02/15/2017292,700
Blackstone Management Associates V L.L.C.10% Owner09/09/2016403,234,623
Blackstone Management Associates V L.L.C.10% Owner06/09/2016215,333,563
WALSH MATTHEW MSee Remarks05/27/20161,959,694
WALSH MATTHEW MSee Remarks05/27/20161,398,010
WALSH MATTHEW MSee Remarks05/27/2016611,533
CARROLL J MARTINDirector09/04/201581,780
Chiminski John RSee Remarks08/17/20152,078,531
Chiminski John RSee Remarks08/17/20151,071,000
Chiminski John RSee Remarks08/19/2015100,263
Chiminski John RSee Remarks08/17/20151,201,590
Chiminski John RSee Remarks08/03/20152,190,873
Chiminski John RSee Remarks08/03/20151,071,000
Chiminski John RSee Remarks08/03/20151,194,126
WALSH MATTHEW MSee Remarks07/27/20151,755,123
WALSH MATTHEW MSee Remarks07/27/2015974,229
WALSH MATTHEW MSee Remarks07/27/2015847,223
Chiminski John RSee Remarks07/20/20151,967,419
Chiminski John RSee Remarks07/20/20151,071,000
Chiminski John RSee Remarks07/20/2015972,581
Chiminski John RSee Remarks07/06/20151,941,486
Chiminski John RSee Remarks07/06/20151,071,000
Chiminski John RSee Remarks07/06/2015992,514
Blackstone Management Associates V L.L.C.10% Owner06/11/201551,898,808
Blackstone Management Associates V L.L.C.10% Owner06/08/2015345,992,042
WALSH MATTHEW MSee Remarks04/06/20152,068,844
WALSH MATTHEW MSee Remarks04/06/20151,092,881
WALSH MATTHEW MSee Remarks04/06/20151,047,979
Houlton ScottSee Remarks04/01/20152,018,301
Houlton ScottSee Remarks04/01/20151,174,870
Houlton ScottSee Remarks04/01/2015497,504
Gennadios AristipposSee Remarks04/01/20151,220,145
Gennadios AristipposSee Remarks04/01/2015734,573
Gennadios AristipposSee Remarks04/01/2015761,209
WALSH MATTHEW MSee Remarks03/27/2015332,274
Leonard StephenSee Remarks03/27/20152,522,303
Leonard StephenSee Remarks03/27/20151,456,560
Leonard StephenSee Remarks03/27/2015934,181
Johnson SharonSee Remarks02/13/2015926,739
Johnson SharonSee Remarks02/17/20151,456,831
Johnson SharonSee Remarks02/17/2015856,691
Johnson SharonSee Remarks02/13/2015529,074
Johnson SharonSee Remarks02/13/2015447,962
Johnson SharonSee Remarks02/17/2015676,314
Kurt NielsenSee Remarks02/17/20151,162,979
Kurt NielsenSee Remarks02/17/2015765,979
Kurt NielsenSee Remarks02/17/2015797,384
Kurt NielsenSee Remarks02/17/2015768,576
Kurt NielsenSee Remarks02/17/2015514,508
Kurt NielsenSee Remarks02/17/2015548,200
Houlton ScottSee Remarks02/13/201553,534
Houlton ScottSee Remarks02/17/2015494
Houlton ScottSee Remarks02/13/201535,268
Houlton ScottSee Remarks02/17/2015334,259
Houlton ScottSee Remarks02/13/201539,592
Houlton ScottSee Remarks02/17/2015360,244
Leonard StephenSee Remarks02/13/201542,737
Leonard StephenSee Remarks02/13/201526,861
Leonard StephenSee Remarks02/13/201528,340
Downie WilliamSee Remarks02/13/2015142,699
Downie WilliamSee Remarks02/17/20152,614,218
Downie WilliamSee Remarks02/13/201566,423
Downie WilliamSee Remarks02/17/20151,488,358
Downie WilliamSee Remarks02/13/201530,089
Downie WilliamSee Remarks02/17/20151,251,900
WALSH MATTHEW MSee Remarks02/13/201589,952
Load More Insider Transactions
FUNDS WITH A POSITION IN CATALENT INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
Capital World Investors9,656,5600.09%-25.28%Growth At A Reasonable Price
BLACKROCK INC.15,196,6470.02%-6.05%Other
VERITAS ASSET MANAGEMENT LLP6,025,4132.47%-6.84%Growth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC4,174,1970.02%3.41%Other
ELLIOTT INVESTMENT MANAGEMENT L.P.4,000,0001.4%No changeActivists
FARALLON CAPITAL MANAGEMENT LLC1,413,0000.3%ExitedEvent Driven, Value
MAGNETAR FINANCIAL LLC999,6281.26%NewEvent Driven, Other
WESTCHESTER CAPITAL MANAGEMENT, LLC981,7252.03%NewEvent Driven
BALYASNY ASSET MANAGEMENT L.P.924,4170.09%NewEvent Driven
ADAGE CAPITAL PARTNERS GP, L.L.C.827,3000.09%202.96%Other
WATER ISLAND CAPITAL LLC544,8603.48%NewEvent Driven
AQR ARBITRAGE LLC534,5461.06%NewEvent Driven
D. E. SHAW & CO., INC.513,3000.02%ExitedOther
GABELLI FUNDS LLC456,1470.19%245.57%Event Driven, Growth, Activists
SAND GROVE CAPITAL MANAGEMENT LLP182,3202.35%NewValue
TUDOR INVESTMENT CORP ET AL130,1290.05%NewEvent Driven, Other
WATER ISLAND CAPITAL LLC100,000 (Call)0.00057%NewEvent Driven
WESTCHESTER CAPITAL MANAGEMENT, LLC50,000 (Put)0.1%NewEvent Driven
ALPINE GLOBAL MANAGEMENT, LLC40,0000.57%NewEvent Driven
BLACKSTONE INC.24,3450.00555%NewOther
CANDRIAM S.C.A.13,8260.00499%8.2%Other
AQR CAPITAL MANAGEMENT LLC9,9250.00095%NewOther
BRIDGEWATER ASSOCIATES, LP9,3210.00234%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR CATALENT INC.
STOCK BUYBACKS FOR CATALENT INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.05%
1Q
03/31/2024
09/30/2023
0.26%
2Q
03/31/2024
06/30/2023
0.26%
3Q
03/31/2024
03/31/2023
0.36%
4Q
03/31/2024
12/31/2022
0.43%
5Q
03/31/2024
09/30/2022
0.47%
6Q
03/31/2024
06/30/2022
0.85%
7Q
03/31/2024
03/31/2022
0.91%
8Q
03/31/2024
12/31/2021
5.58%
9Q
03/31/2024
09/30/2021
5.83%
10Q
03/31/2024
06/30/2021
6.10%
11Q
03/31/2024
03/31/2021
6.17%
12Q
03/31/2024
12/31/2020
9.74%
13Q
03/31/2024
09/30/2020
10.11%
14Q
03/31/2024
06/30/2020
16.68%
15Q
03/31/2024
03/31/2020
23.44%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.05%
1Q
09/30/2023
0.26%
2Q
06/30/2023
0.26%
3Q
03/31/2023
0.36%
4Q
12/31/2022
0.43%
5Q
09/30/2022
0.47%
6Q
06/30/2022
0.85%
7Q
03/31/2022
0.91%
8Q
12/31/2021
5.58%
9Q
09/30/2021
5.83%
10Q
06/30/2021
6.10%
11Q
03/31/2021
6.17%
12Q
12/31/2020
9.74%
13Q
09/30/2020
10.11%
14Q
06/30/2020
16.68%
15Q
03/31/2020
23.44%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CATALENT INC.
LOADING...